SEAN FORSYTH: Open Payments
NPI 1598159568 · MILLSBORO, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,052 in 37 payments from 20 companies in 2025. Trend: 2023 $198 · 2024 $1,244 · 2025 $1,052
Food & beverage: $1,052
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 6 | $352 |
| Lilly USA, LLC | 4 | $159 |
| Novo Nordisk Inc | 3 | $74 |
| Verona Pharma, Inc. | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Neurelis, Inc. | 2 | $33 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Lundbeck LLC | 1 | $27 |
| GENZYME CORPORATION | 1 | $26 |
Products named: INSPIRE, ZEPBOUND, Ohtuvayre, MOUNJARO, JARDIANCE, VALTOCO, Ozempic, GARDASIL 9.
Industry payments across DE — which companies pay providers there.
